Natural Eggshell Membrane (NEM®), a novel dietary supplement, has demonstrated significant efficacy and safety in the management of knee osteoarthritis, particularly in patients experiencing severe joint pain and stiffness. The study, "Efficacy and Safety of Natural Eggshell Membrane (NEM®) in Patients with Grade 2/3 Knee Osteoarthritis: A Multi-Center, Randomized, Double-blind, Placebo-Controlled, Single-crossover Clinical Study" by Eskiyurt et al. (2019), presents compelling evidence of NEM's therapeutic benefits.
This extensive clinical trial revealed that subjects treated with NEM experienced substantial reductions in joint pain, stiffness, and functional limitations within just 7 to 30 days of treatment, with continued improvements observed over 90 days. These outcomes not only underscore NEM's rapid action but also its long-term benefits in enhancing joint flexibility and overall quality of life for individuals with knee osteoarthritis.
NEM's mechanism, leveraging the natural composition of eggshell membrane, provides a safe, effective alternative to conventional treatments, offering new hope for millions suffering from the debilitating effects of osteoarthritis. This study highlights NEM's potential as a pivotal component in the comprehensive clinical management of knee osteoarthritis, promising enhanced mobility and pain relief for those in need.
References
- Eskiyurt, N., Sarıdoğan, M., Şenel, K., Günaydın, R., Erdal, A., Özyiğit, E., Akarırmak, Ü., Şendur, Ö., Barut, K., Akyuz, G., Ozsoy, T., Tuncer, T., Karataş, Ö., İrdesel, J., Ketenci, A., & Aydoğan, C. (2019). Efficacy and Safety of Natural Eggshell Membrane (NEM®) in Patients with Grade 2/3 Knee Osteoarthritis: A Multi-Center, Randomized, Double-blind, Placebo-Controlled, Single-crossover Clinical Study. Journal of The American Helicopter Society, 8, 1-7. Efficacy and Safety of Natural Eggshell Membrane (NEM®) in Patients with Grade 2/3 Knee Osteoarthritis: A Multi-Center, Randomized, Doubleblind, Placebo-Controlled, Single-crossover Clinical Study
